Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

摘要

The American Joint Committee on Cancer staging and other prognostic tools fail to account for stage-independent variability in outcome. We developed a prognostic classifier adding Immunoscore to clinicopathological and molecular features in patients with stage III colon cancer.